KD Logo

Analyzing Generation Bio Co (GBIO) After Recent Trading Activity

Generation Bio Co’s recent filing unveils that its CHIEF STRATEGY OFFICER Samayoa Phillip unloaded Company’s shares for reported $3961.0 on Jan 02 ’24. In the deal valued at $1.62 per share,2,445 shares were sold. As a result of this transaction, Samayoa Phillip now holds 107,256 shares worth roughly $0.38 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Paone Antoinette sold 2,445 shares, generating $3,961 in total proceeds. Upon selling the shares at $1.62, the CHIEF OPERATING OFFICER now owns 5,828 shares.

Before that, Appelhans Dannielle bought 7,363 shares. Generation Bio Co shares valued at $13,180 were divested by the Director at a price of $1.79 per share. As a result of the transaction, Appelhans Dannielle now holds 7,363 shares, worth roughly $26065.02.

TD Cowen downgraded its Generation Bio Co [GBIO] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. William Blair also remained covering GBIO and has decreased its forecast on December 14, 2021 with a “Mkt perform” recommendation from previously “an Outperform” rating. JMP Securities started covering the stock on June 08, 2021. It rated GBIO as “a Mkt outperform”.

Price Performance Review of GBIO

On Tuesday, Generation Bio Co [NASDAQ:GBIO] saw its stock jump 24.65% to $3.54. Over the last five days, the stock has gained 11.32%. Generation Bio Co shares have risen nearly 114.55% since the year began. Nevertheless, the stocks have fallen -21.85% over the past one year. While a 52-week high of $6.98 was reached on 04/01/24, a 52-week low of $0.86 was recorded on 01/02/24. SMA at 50 days reached $3.30, while 200 days put it at $2.79. A total of 0.38 million shares were traded, compared to the trading of 0.26 million shares in the previous session.

Levels Of Support And Resistance For GBIO Stock

The 24-hour chart illustrates a support level at 3.28, which if violated will result in even more drops to 3.03. On the upside, there is a resistance level at 3.78. A further resistance level may holdings at 4.03. The Relative Strength Index (RSI) on the 14-day chart is 57.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.96%. Stochastics %K at 34.99% indicates the stock is a holding.

The most recent change occurred on February 24, 2021 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating.

Most Popular